Patents by Inventor George N. Paradissis
George N. Paradissis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6696083Abstract: The efficacy of vitamins and other nutritional agents in treating and preventing various disease states is improved by administering therapeutically effective levels of these agents on a substantially continuous, 24-hour basis. The concentration of lipid peroxides formed by the autoxidation of lipids, and the concentration of oxygen free radicals, are reduced by continuously administering antioxidant agents. The regeneration of nerve tissue is improved by continuously administering at least one pharmaceutically-acceptable B complex vitamin.Type: GrantFiled: January 30, 1998Date of Patent: February 24, 2004Assignee: DrugTech CorporationInventors: George N. Paradissis, R. Saul Levinson, Mitchell I. Kirschner, Marc S. Hermelin
-
Publication number: 20030068372Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.Type: ApplicationFiled: December 3, 2002Publication date: April 10, 2003Applicant: Drugtech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
-
Publication number: 20020187205Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.Type: ApplicationFiled: July 31, 2002Publication date: December 12, 2002Applicant: K-V Pharmaceutical CompanyInventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
-
Patent number: 6488956Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.Type: GrantFiled: November 24, 1999Date of Patent: December 3, 2002Assignee: Drugtech CorporationInventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
-
Publication number: 20020034543Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.Type: ApplicationFiled: September 12, 2001Publication date: March 21, 2002Applicant: DRUGTECH CORPORATIONInventors: Mitchell I. Kirschner, R. Saul Levison, George N. Paradissis
-
Patent number: 6352713Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.Type: GrantFiled: December 1, 1999Date of Patent: March 5, 2002Assignee: Drugtech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
-
Patent number: 5869084Abstract: Multi-vitamin and mineral supplements for administration to lactating, non-lactating, and menopausal women, which comprise specific regimens of critical nutritional agents. The supplements are specifically tailored to meet nutritional requirements and maintain a woman's health during each stage of life.Type: GrantFiled: June 7, 1995Date of Patent: February 9, 1999Assignee: K-V Pharmaceuticals Co.Inventors: George N. Paradissis, R. Saul Levinson, Gary Heeter, Robert C. Cuca, Patrick Paul Vanek
-
Patent number: 5445829Abstract: An extended release pharmaceutical formulation adapted to approach zero order release of drug over a 12 to at least 24 hour period, comprised of a mixture of 0 to about 50% of an immediate release particle containing a drug, inert substrate and binder, coated with talc and up to 100% of an extended release particle comprising the immediate release particle coated with a dissolution modifying system containing plasticizers and a film forming agent.Type: GrantFiled: June 15, 1992Date of Patent: August 29, 1995Assignee: KV Pharmaceutical CompanyInventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
-
Patent number: 5296232Abstract: A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core composed of a pharmaceutically acceptable, film forming polymer. The film forming polymer is effective to permit release of the organic nitrate from the spheres, over a daily dosing period, at a rate that achieves a therapeutically effective level of the organic nitrate, while effecting a drug holiday towards a latter portion of the daily dosing period so as not to induce tolerance.Type: GrantFiled: May 13, 1992Date of Patent: March 22, 1994Assignee: KV Pharmaceutical CompanyInventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
-
Patent number: 5133974Abstract: An extended release pharmaceutical formulation adapted to approach zero order release of drug over a 12 to at least 24 hour period, comprised of a mixture of 0 to aobut 50% of an immediate release particle containing a drug, inert substrate and binder, coated with talc and up to 100% of an extended release particle comprising the immediate release particle coated with a dissolution modifying system containing plasticizers and a film forming agent.Type: GrantFiled: January 24, 1990Date of Patent: July 28, 1992Assignee: KV Pharmaceutical CompanyInventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
-
Patent number: 5122384Abstract: A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core composed of a pharmaceutically acceptable, film forming polymer. The film forming polymer is effective to permit release of the organic nitrate from the spheres, over a daily dosing period, at a rate that achieves a therapeutically effective level of the organic nitrate, while effecting a drug holiday towards a latter portion of the daily dosing period so as not to induce tolerance.Type: GrantFiled: May 5, 1989Date of Patent: June 16, 1992Assignee: KV Pharmaceutical CompanyInventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
-
Patent number: 4973480Abstract: A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.Type: GrantFiled: June 23, 1989Date of Patent: November 27, 1990Assignee: K.V. Pharmaceutical Co.Inventors: Marc S. Hermelin, Mitchell I. Kirschner, George N. Paradissis
-
Patent number: 4844906Abstract: A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.Type: GrantFiled: March 25, 1987Date of Patent: July 4, 1989Assignee: KV Pharmaceutical CompanyInventors: Marc S. Hermelin, Mitchell I. Kirschner, George N. Paradissis
-
Patent number: 4764375Abstract: A drug delivery system in which a taste masked solid is suspended in a liquid carrier. The solid has been rendered hydrophillic and its density approximates that of the carrier liquid.Type: GrantFiled: September 11, 1985Date of Patent: August 16, 1988Assignee: KV Pharmaceutical CompanyInventor: George N. Paradissis